Combination pharmacotherapy for stopping smoking: what advantages does it offer?
about
Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trialsTranslational research in nicotine dependenceSmoking cessation and the cardiovascular patientThe Past, Present, and Future of Nicotine Addiction TherapyTreatment of nicotine addiction: present therapeutic options and pipeline developments.Varenicline for smoking cessation: efficacy, safety, and treatment recommendationsShould all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy.Nicotine vaccines to assist with smoking cessation: current status of research.Pharmacotherapy for smoking cessation: current advances and research topics.Pharmacological interventions for the treatment of smokeless tobacco use.Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.Medications for substance use disorders.Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction?The effect of acute exercise on cigarette cravings while using a nicotine lozenge.Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial.Is nicotine replacement therapy overvalued in smoking cessation? Analysis of smokers' and quitters' communication in social media.Handling relapse in smoking cessation: strategies and recommendations.Tobacco use disorder and treatment: new challenges and opportunities.The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.
P2860
Q26801320-14712B02-32E7-45B2-93D6-491FF3A5E37DQ26852485-D0D856D0-46DD-4AAB-B9D6-6EFADEF47D0FQ28082695-FC9A05A6-86E8-41D4-9947-52962CD076ECQ28088508-A10C580E-2B44-448D-A1D2-7BB8EC6C9013Q30398847-7F5796A7-EC8F-467F-BB07-D8C6994D8D9FQ34231551-06827991-095E-4BA7-B92A-0391E797A609Q35693641-B1E13E5C-0A6C-4B0D-BA24-E80529BB743BQ36987118-275E982C-3241-484F-BC35-4F21D4A477B3Q37863092-F2EF342A-90FE-42E8-A2C2-603E5D29A045Q37963943-D6D59344-697D-48E2-B13F-95A469730EE4Q38031894-7C9F70F2-D623-4239-867F-012A53AE644CQ38111473-F274C7D6-6BA2-418C-8AC9-FD7F12EB1F64Q38129470-9E323D1D-7E29-4012-A8A5-BC1362998B19Q39193842-F38AEE62-2784-4375-BEFF-BA1CDF38E1B8Q41638053-B9491FEA-D4B3-46DE-8D66-2ACB540FEFB5Q44195131-E60986F0-6E92-40EE-B3BF-853939C7D775Q44270991-59C75B74-F254-486A-90D5-655D65E4E9ABQ47130262-C9F8659D-CC97-46A3-9EAF-7B278CC1CC7BQ53825728-41CCA2E2-B0A9-4A68-B91E-0E5BCA7BA995
P2860
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
@ast
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
@en
type
label
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
@ast
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
@en
prefLabel
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
@ast
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
@en
P2093
P2860
P1433
P1476
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
@en
P2093
J Taylor Hays
Jon O Ebbert
Richard D Hurt
P2860
P304
P356
10.2165/11536100-000000000-00000
P577
2010-04-01T00:00:00Z
P5875
P6179
1009033890